Patents Assigned to Angioscore, Inc.
-
Patent number: 11571554Abstract: An angioplasty balloon including a non-deployable stent to prevent or reduce the potential for slippage of the inflated balloon with respect to the vessel wall being treated. The balloon includes a non-deployable stent that is adapted to be secured to the balloon or angioplasty balloon catheter. The stent has a proximal end, a distal end, and at least three radially-spaced struts, each, each strut connecting the proximal end to the distal end and having one or more bends that allow expansion of the strut to accommodate the inflation of the balloon. The stem is made or a material so that the stent collapses upon deflation of the balloon.Type: GrantFiled: June 5, 2012Date of Patent: February 7, 2023Assignee: ANGIOSCORE, INC.Inventor: Robert C. Farnan
-
Patent number: 11420030Abstract: Angioplasty and other dilatation devices are provided with scoring elements which incorporate a drug to be delivered to a body lumen, typically a blood vessel. The scoring elements have drugs and other active substances coated over a portion thereof or incorporated within internal structure of the element so that the drug is released into the luminal wall closely associated diseased regions of the body lumen as the scoring structure is radially expanded into the wall.Type: GrantFiled: June 7, 2019Date of Patent: August 23, 2022Assignee: ANGIOSCORE, INC.Inventors: Eitan Konstantino, Michal Konstantino
-
Patent number: 10736652Abstract: A valvuloplasty catheter comprises a balloon or other expansible shell which carries a plurality of scoring elements, typically formed in an elastic, self-closing metal cage. The expansible shell and scoring elements are positioned inside an aortic or other cardiac valve, and the shell expanded to engage the scoring elements against stenotic material which covers the valve leaflets and valve annulus. The scoring elements uniformly distributed force to break up the stenotic material, and the cage further contributes to rapid balloon deflation allowing shortening of the treatment time.Type: GrantFiled: May 25, 2016Date of Patent: August 11, 2020Assignee: ANGIOSCORE, INC.Inventors: Gary Gershony, David Doty
-
Patent number: 10722694Abstract: An angioplasty catheter has a catheter body having a balloon or other radially expandable shell at its distal end. A non-axial external structure is carried over the shell and scores a stenosed region in a blood vessel when the balloon is inflated therein. The catheter has an attachment structure disposed between the catheter body and the balloon to accommodate foreshortening and rotation of the external structure as the balloon is expanded. The external structure may be part of a helical cage structure which floats over the balloon.Type: GrantFiled: March 28, 2018Date of Patent: July 28, 2020Assignee: ANGIOSCORE, INC.Inventors: Eitan Konstantino, Tanhum Feld, Nimrod Tzori
-
Patent number: 10583225Abstract: The present invention is related to scoring or cutting balloon catheters carrying at least on a portion of their surface at least one oxidation-insensitive drug or oxidation-insensitive polymer free drug preparation and at least one lipophilic antioxidant at a ratio of 3-100% by weight of the at least one lipophilic antioxidant in relation to 100% by weight of the drug, wherein the at least one oxidation-insensitive drug is selected of taxes, thalidomide, statins, corticoids and lipophilic derivatives of corticoids, and the at least one lipophilic antioxidant is selected of nordihydroguaiaretic acid, resveratrol and propyl gallate.Type: GrantFiled: June 18, 2019Date of Patent: March 10, 2020Assignee: ANGIOSCORE, INC.Inventors: Ulrich Speck, Madeleine Caroline Berg
-
Patent number: 10485571Abstract: An angioplasty catheter comprises a catheter body having a balloon or other radially expandable shell at its distal end. An external structure is carried over the shell and scores a stenosed region in a blood vessel when the balloon is inflated therein. The catheter has an attachment structure disposed between the catheter body and the balloon to accommodate foreshortening and rotation of the external structure as the balloon is expanded. The external structure may be part of a helical cage structure which floats over the balloon. Stabilizing struts are provided between at least some of the helical struts.Type: GrantFiled: December 9, 2016Date of Patent: November 26, 2019Assignee: ANGIOSCORE, INC.Inventors: Meir Moffarah, Jeffrey Bleam, Peter E. Wagner
-
Patent number: 10471184Abstract: The present invention is related to scoring or cutting balloon catheters carrying at least on a portion of their surface at least one drug or drug preparation and at least one lipophilic antioxidant at a ratio of 3-100% by weight of the at least one lipophilic antioxidant in relation to 100% by weight of the drug, wherein a combination of the at least one drug being a limus drug and the at least one lipophilic antioxidant being butylated hydroxytoluene is excluded.Type: GrantFiled: May 14, 2019Date of Patent: November 12, 2019Assignee: ANGIOSCORE, INC.Inventors: Ulrich Speck, Madeline Caroline Berg
-
Patent number: 10383982Abstract: The present invention is related to scoring or cutting balloon catheters carrying at least on a portion of their surface at least one oxidation-insensitive drug or oxidation-insensitive polymer-free drug preparation and at least one lipophilic antioxidant at a ratio of 3-100% by weight of the at least one lipophilic antioxidant in relation to 100% by weight of the drug, wherein the at least one oxidation-insensitive drug is selected of taxanes, thalidomide, statins, corticoids and lipophilic derivatives of corticoids, and the at least one lipophilic antioxidant is selected of nordihydroguaiaretic acid, resveratrol and propyl gallate.Type: GrantFiled: August 13, 2018Date of Patent: August 20, 2019Assignee: ANGIOSCORE, INC.Inventors: Ulrich Speck, Madeleine C. Berg
-
Patent number: 10342960Abstract: Angioplasty and other dilatation devices are provided with scoring elements which incorporate a drug to be delivered to a body lumen, typically a blood vessel. The scoring elements have drugs and other active substances coated over a portion thereof or incorporated within internal structure of the element so that the drug is released into the luminal wall closely associated diseased regions of the body lumen as the scoring structure is radially expanded into the wall.Type: GrantFiled: February 13, 2017Date of Patent: July 9, 2019Assignee: AngioScore, Inc.Inventors: Eitan Konstantino, Michal Konstantino
-
Patent number: 10314947Abstract: The present invention is related to scoring or cutting balloon catheters carrying at least on a portion of their surface at least one drug or drug preparation and at least one lipophilic antioxidant at a ratio of 3-100% by weight of the at least one lipophilic antioxidant in relation to 100% by weight of the drug, wherein a combination of the at least one drug being a limus drug and the at least one lipophilic antioxidant being butylated hydroxytoluene is excluded.Type: GrantFiled: July 31, 2017Date of Patent: June 11, 2019Assignee: Angioscore, Inc.Inventors: Ulrich Speck, Madeleine Caroline Berg
-
Patent number: 10086178Abstract: An angioplasty balloon including a non-deployable stent to prevent or reduce the potential for slippage of the inflated balloon with respect to the vessel wall being treated. The balloon includes a non-deployable stent that is adapted to be secured to the balloon or angioplasty balloon catheter. The stent has a proximal end, a distal end, and at least one extension section, at least one set of serpentine rings and at least one set of elongation links that allow expansion of the strut to accommodate the inflation of the balloon. The stent is made of a material so that the stent collapses upon deflation of the balloon.Type: GrantFiled: February 7, 2011Date of Patent: October 2, 2018Assignee: ANGIOSCORE, INC.Inventors: Robert C. Farnan, Dirk Voland Hoyns, Anand Ram
-
Patent number: 9962529Abstract: An angioplasty catheter comprises a catheter body having a balloon or other radially expandable shell at its distal end. A non-axial external structure is carried over the shell and scores a stenosed region in a blood vessel when the balloon is inflated therein. The catheter has an attachment structure disposed between the catheter body and the balloon to accommodate foreshortening and rotation of the external structure as the balloon is expanded. The external structure may be part of a helical cage structure which floats over the balloon.Type: GrantFiled: May 12, 2014Date of Patent: May 8, 2018Assignee: Angioscore, Inc.Inventors: Eitan Konstantino, Tanhum Feld, Nimrod Tzori
-
Patent number: 9770536Abstract: The present invention is related to scoring or cutting balloon catheters carrying at least on a portion of their surface at least one drug or drug preparation and at least one lipophilic antioxidant at a ratio of 3-100% by weight of the at least one lipophilic antioxidant in relation to 100% by weight of the drug, wherein a combination of the at least one drug being a limus drug and the at least one lipophilic antioxidant being butylated hydroxytoluene is excluded.Type: GrantFiled: October 7, 2015Date of Patent: September 26, 2017Assignee: Angioscore, Inc.Inventors: Ulrich Speck, Madeleine Caroline Berg
-
Patent number: 9586031Abstract: Angioplasty and other dilatation devices are provided with scoring elements which incorporate a drug to be delivered to a body lumen, typically a blood vessel. The scoring elements have drugs and other active substances coated over a portion thereof or incorporated within internal structure of the element so that the drug is released into the luminal wall closely associated diseased regions of the body lumen as the scoring structure is radially expanded into the wall.Type: GrantFiled: March 15, 2013Date of Patent: March 7, 2017Assignee: AngioScore, Inc.Inventors: Eitan Konstantino, Michal Konstantino
-
Patent number: 9375328Abstract: An angioplasty balloon including a non-deployable stent to prevent or reduce the potential for slippage of the inflated balloon with respect to the vessel wall being treated. The balloon includes a non-deployable stent that is adapted to be secured to the balloon or angioplasty balloon catheter. The stent has a proximal end, a distal end, and at least three radially-spaced struts, each, each strut connecting the proximal end to the distal end and having one or more bends that allow expansion of the strut to accommodate the inflation of the balloon. The stent is made or a material so that the stent collapses upon deflation of the balloon.Type: GrantFiled: January 26, 2010Date of Patent: June 28, 2016Assignee: AngioScore, Inc.Inventor: Robert C. Farnan
-
Patent number: 9364254Abstract: A valvuloplasty catheter comprises a balloon or other expansible shell which carries a plurality of scoring elements, typically formed in an elastic, self-closing metal cage. The expansible shell and scoring elements are positioned inside an aortic or other cardiac valve, and the shell expanded to engage the scoring elements against stenotic material which covers the valve leaflets and valve annulus. The scoring elements uniformly distributed force to break up the stenotic material, and the cage further contributes to rapid balloon deflation allowing shortening of the treatment time.Type: GrantFiled: May 15, 2013Date of Patent: June 14, 2016Assignee: AngioScore, Inc.Inventors: Gary Gershony, David Doty
-
Patent number: 9351756Abstract: A valvuloplasty catheter comprises a balloon or other expansible shell which carries a plurality of scoring elements, typically formed in an elastic, self-dosing metal cage. The expansible shell and scoring elements are positioned inside an aortic or other cardiac valve, and the shell expanded to engage the scoring elements against stenotic material which covers the valve leaflets and valve annulus. The scoring elements uniformly districuted force to break up the stenotic material, and the cage further contributes to rapid balloon deflation allowing shortening of the treatment time.Type: GrantFiled: August 27, 2013Date of Patent: May 31, 2016Assignee: AngioScore, Inc.Inventors: Gary Gershony, David Doty
-
Patent number: 9173977Abstract: The present invention is related to scoring or cutting balloon catheters carrying at least on a portion of their surface at least one drug or drug preparation and at least one lipophilic antioxidant at a ratio of 3-100% by weight of the at least one lipophilic antioxidant in relation to 100% by weight of the drug, wherein a combination of the at least one drug being a limus drug and the at least one lipophilic antioxidant being butylated hydroxytoluene is excluded.Type: GrantFiled: September 27, 2012Date of Patent: November 3, 2015Assignee: AngioScore, Inc.Inventors: Ulrich Speck, Madeleine Caroline Berg
-
Patent number: 9101684Abstract: The present invention is related to scoring or cutting balloon catheters carrying at least on a portion of their surface at least one oxidation-insensitive drug or oxidation-insensitive polymer-free drug preparation and at least one lipophilic antioxidant at a ratio of 3-100% by weight of the at least one lipophilic antioxidant in relation to 100% by weight of the drug, wherein the at least one oxidation-insensitive drug is selected of taxanes, thalidomide, statins, corticoids and lipophilic derivatives of corticoids, and the at least one lipophilic antioxidant is selected of nordihydroguaiaretic acid, resveratrol and propyl gallate.Type: GrantFiled: August 23, 2013Date of Patent: August 11, 2015Assignee: ANGIOSCORE, INC.Inventors: Ulrich Speck, Madeleine Caroline Berg
-
Patent number: 9078951Abstract: The present invention is related to scoring or cutting balloon catheters carrying at least on a portion of their surface at least one oxidation-insensitive drug or oxidation-insensitive polymer-free drug preparation and at least one lipophilic antioxidant at a ratio of 3-100% by weight of the at least one lipophilic antioxidant in relation to 100% by weight of the drug, wherein the at least one oxidation-insensitive drug is selected of taxanes, thalidomide, statins, corticoids and lipophilic derivatives of corticoids, and the at least one lipophilic antioxidant is selected of nordihydroguaiaretic acid, resveratrol and propyl gallate.Type: GrantFiled: August 23, 2013Date of Patent: July 14, 2015Assignee: ANGIOSCORE, INC.Inventors: Ulrich Speck, Madeleine Caroline Berg